Saponins from Momordica charantia exert hypoglycemic effect in diabetic mice by multiple pathways
Open Access
- 18 September 2023
- journal article
- research article
- Published by Wiley in Food Science & Nutrition
- Vol. 11 (12) , 7626-7637
Abstract
The antidiabetic activity of saponins extracted from Momordica charantia (MCS) on streptozotocin‐induced diabetic mice was investigated in order to elucidate the mechanism of MCS for exerting hypoglycemic effects. Saponins were first extracted from M. charantia L. and their composition was analyzed. The diabetic Kunming mice were fed low‐dose saponins from M. charantia L. and high‐dose MCS, using normal mice and diabetic mice as controls. Body weight, blood glucose level, oral glucose tolerance, serum C‐peptide level, hepatic antioxidant capacity, hepatic glycogen and hexokinase in liver tissues, serum blood lipid level, and alpha‐glucosidase activity in small intestines were measured, and microstructure of pancreatic islet was analyzed. The results showed that the total content of seven triterpenoid compounds in MCS was 18.24 μg/mg, with Momordicoside K having the highest content at 11.66 μg/mg. Diabetic mice treated with MCS at 100 and 200 mg/kg body weight daily for 30 days showed a maximum glucose reduction (p < .05) of 12.63% and 26.47%, respectively. MCS significantly decreased levels of postprandial hyperglycemia, serum lipid, α‐glucosidase activity, and liver malondialdehyde. Additionally, levels of serum C‐peptide and liver glycogen, as well as hexokinase and antioxidant enzyme activity, were significantly increased compared to the diabetic control groups. Histopathological results showed that MCS markedly reduced degenerative changes in islet β‐cells. It is concluded that MCS exerts antidiabetic effects by improved hypoglycemic, hypolipidemic, and antioxidant effects, increased hexokinase activity and glycogen synthesis, and enhanced reparative effects on the histological architecture and insulin secretion function of the pancreas.Keywords
This publication has 41 references indexed in Scilit:
- Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitroPhytomedicine, 2011
- Enhanced insulin secretion and sensitization in diabetic mice on chronic treatment with a transient receptor potential vanilloid 1 antagonistLife Sciences, 2011
- Traditional Chinese Medicines in Treatment of Patients with Type 2 Diabetes MellitusEvidence-Based Complementary and Alternative Medicine, 2011
- Momordica charantia (bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genesBMC Complementary and Alternative Medicine, 2010
- Bitter melon (Momordica charantia) triterpenoid extract reduces preadipocyte viability, lipid accumulation and adiponectin expression in 3T3-L1 cellsFood and Chemical Toxicology, 2010
- Evaluation of in vivo antioxidant activities of Ganoderma lucidum polysaccharides in STZ-diabetic ratsFood Chemistry, 2009
- Antidiabetic Activities of Triterpenoids Isolated from Bitter Melon Associated with Activation of the AMPK PathwayChemistry & Biology, 2008
- α-Glucosidase inhibitory activity of the methanolic extract from Tournefortia hartwegiana: An anti-hyperglycemic agentJournal of Ethnopharmacology, 2007
- Using Bitter Melon to Treat DiabetesAlternative and Complementary Therapies, 2005
- Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitusJournal of Ethnopharmacology, 2004